中国高校科技期刊研究会第9次会员代表大会在北京召开，中宣部出版局副局长张怀海、教育部科学技术与信息化司一级巡视员张国辉等领导出席会议并发表..
英文简介：Contemporary biomedical research is on the threshold of an era in which physiological and pathological processes can be analyzed in increasingly precise and mechanistic terms. The transformation of biology from a largely descriptive, phenomenological discipline to one in which the regulatory principles can be understood and manipulated with predictability brings a new dimension to the study of cancer and the search for effective therapeutic modalities for this disease. Cancer and Metastasis Reviews provides a forum for critical review and discussion of these challenging developments.Each issue of Cancer and Metastasis Reviews is devoted to a particular theme or topic and will contain from five to seven different contributions. In addition, an introductory preface is included from an individual who is distinguished in the field to be covered. The topics and contributors are chosen by the Editor-in-Chief after consultation with various members of the Editorial Advisory Board. Special emphasis is placed on subjects which are of relevance to the molecular and cellular biology of cancer metastasis and tumor progression, as well as to the treatment of metastatic disease. Occasional issues will be devoted to an in-depth clinical and biological analysis of a particular type of cancer.A major function of the journal is to review some of the more important and interesting recent developments in the biology and treatment of malignant disease, as well as to highlight new and promising directions, be they technological or conceptual. Contributors are encouraged to review their personal work and be speculative.中文简介：（来自Google、百度翻译）当代生物医学研究正处于一个时代的门槛，在这个时代，可以用越来越精确和机械的术语来分析生理和病理过程。生物学从主要是描述性的现象学学科转变为可以理解和控制具有可预测性的调节原理的学科，为癌症的研究和寻找有效的治疗方法带来了新的维度。癌症和转移评论提供了一个论坛，用于对这些具有挑战性的发展进行批判性审查和讨论。 每期癌症和转移评论专门针对特定主题或主题，并将包含五到七个不同的贡献。此外，还包括在要涵盖的领域中与众不同的个人的介绍性前言。主题和贡献者由主编在与编辑顾问委员会的各个成员协商后选择。特别强调与癌症转移和肿瘤进展的分子和细胞生物学以及转移性疾病的治疗相关的主题。偶尔的问题将致力于对特定类型癌症进行深入的临床和生物学分析。 该杂志的主要功能是回顾一些更重要和有趣的最新进展在生物学和恶性疾病的治疗，以及突出新的和有前途的方向，无论是技术上的还是概念上的。鼓励贡献者审查其个人工作并进行投机。
